U.S. flag

An official website of the United States government

Format
Items per page

Send to:

Choose Destination

Links from PubChem Compound

Items: 10

1.

vidarabine 5'-valerate [Supplementary Concept]

prodrug of vidarabine

Date introduced: August 29, 1980

2.

Purines

A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.

3.

Purine Nucleosides

Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES.

Year introduced: 1974

4.

Nucleic Acids, Nucleotides, and Nucleosides

Complex compounds of high molecular weight occurring in living cells. These are basically of two types, ribonucleic (RNA) and deoxyribonucleic (DNA) acids, both of which consist of nucleotides (nucleoside phosphates linked together by phosphate bridges).

Year introduced: 1998

5.

Nucleosides

Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King and Stansfield, A Dictionary of Genetics, 4th ed)

6.

Heterocyclic Compounds, 2-Ring

A class of heterocyclic compounds that include a two-ring fused structure. Both aromatic and non-aromatic ring structures are included in this category.

Year introduced: 1998

7.

Heterocyclic Compounds

Cyclic compounds that include atoms other than carbon in their ring structure.

8.

Arabinonucleosides

Nucleosides containing arabinose as their sugar moiety.

Year introduced: 1979

9.

Adenosine

A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.

Year introduced: 1972

10.

Heterocyclic Compounds, Fused-Ring

Multiple ring heterocyclic compounds containing two or more rings that share two atoms and one bond in common.

Year introduced: 2017

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Loading ...